Healthleap, a clinical AI startup, secured $38 million in combined seed and Series A funding. The financing includes an $8 million seed round led by Sequoia Capital and First Round Capital, alongside a $30 million Series A round led by Hummingbird Ventures. The company did not disclose its valuation.
Founded in 2022 by Josiah and Jemima Meyer, the startup provides software that integrates with electronic health record systems. It analyzes daily patient data, including lab results and clinician notes, to generate risk scores for potential undiagnosed conditions. The system currently focuses on malnutrition, with plans to expand into 40 other conditions.
The platform has demonstrated financial and clinical results. At the Hospital of the University of Pennsylvania, the program generated an annualized financial impact of $23.8 million, including $6.3 million in additional reimbursements and 8,632 saved bed-days. Cedars-Sinai reported an 11 million USD annual impact and a 39% increase in malnutrition diagnoses.
A peer-reviewed study in Applied Clinical Informatics, covering over 166,000 admissions, showed the system had 88% higher sensitivity than standard screening tools. The company has expanded from three to over 50 hospital partners in the past year, including Houston Methodist and Emory Healthcare, with revenue increasing more than tenfold during that period.
The new capital will be allocated toward engineering, product development, sales, and customer success. The company aims to scale its software to hundreds of additional hospitals and eventually extend its reach beyond inpatient care into outpatient and home care settings.
